Changmao Biochemical Engineering Company Limited (HKG:0954)
Hong Kong · Delayed Price · Currency is HKD 0.3250
+0.0150 (4.84%)
Jun 12, 2026, 1:50 PM HKT
HKG:0954 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 556.93 | 584.79 | 637.08 | 730.03 | 547.98 | |
Revenue Growth (YoY) | -4.77% | -8.21% | -12.73% | 33.22% | 23.39% |
Cost of Revenue | 528.36 | 567.09 | 572.72 | 549.2 | 491.74 |
Gross Profit | 28.57 | 17.71 | 64.36 | 180.83 | 56.23 |
Selling, General & Admin | 75.63 | 81.02 | 49.31 | 88.09 | 81.7 |
Other Operating Expenses | -9.63 | -6.64 | -6.56 | -3.61 | -4.66 |
Operating Expenses | 66.01 | 74.38 | 42.75 | 84.48 | 77.03 |
Operating Income | -37.44 | -56.68 | 21.61 | 96.35 | -20.8 |
Interest Expense | -17.23 | -11.36 | -7.58 | -2.67 | -1.95 |
Interest & Investment Income | 0.63 | 0.85 | 1.05 | 0.94 | 0.54 |
Currency Exchange Gain (Loss) | -0.08 | 2.94 | -0.25 | 7.77 | -1.69 |
EBT Excluding Unusual Items | -54.11 | -64.25 | 14.84 | 102.39 | -23.91 |
Gain (Loss) on Sale of Investments | 0.02 | 0.22 | 0.27 | -1.53 | 1.05 |
Gain (Loss) on Sale of Assets | -0.13 | -2.62 | -1.14 | -4.35 | -1.67 |
Asset Writedown | -10.74 | -0.93 | -72.55 | -8.88 | -17.55 |
Other Unusual Items | - | - | - | - | 126.49 |
Pretax Income | -64.96 | -67.58 | -58.58 | 87.64 | 84.41 |
Income Tax Expense | 2.21 | 0.67 | 27.94 | 6.29 | 26.2 |
Earnings From Continuing Operations | -67.17 | -68.25 | -86.52 | 81.36 | 58.21 |
Minority Interest in Earnings | 0.41 | 0.01 | 0.46 | 0.07 | 0.11 |
Net Income | -66.76 | -68.24 | -86.06 | 81.42 | 58.32 |
Net Income to Common | -66.76 | -68.24 | -86.06 | 81.42 | 58.32 |
Net Income Growth | - | - | - | 39.62% | 246.57% |
Shares Outstanding (Basic) | 530 | 530 | 530 | 530 | 530 |
Shares Outstanding (Diluted) | 530 | 530 | 530 | 530 | 530 |
EPS (Basic) | -0.13 | -0.13 | -0.16 | 0.15 | 0.11 |
EPS (Diluted) | -0.13 | -0.13 | -0.16 | 0.15 | 0.11 |
EPS Growth | - | - | - | 39.62% | 246.57% |
Free Cash Flow | 10.69 | -96.28 | -141.52 | -203.89 | -183.53 |
Free Cash Flow Per Share | 0.02 | -0.18 | -0.27 | -0.39 | -0.35 |
Dividend Per Share | - | - | - | 0.077 | - |
Gross Margin | 5.13% | 3.03% | 10.10% | 24.77% | 10.26% |
Operating Margin | -6.72% | -9.69% | 3.39% | 13.20% | -3.80% |
Profit Margin | -11.99% | -11.67% | -13.51% | 11.15% | 10.64% |
Free Cash Flow Margin | 1.92% | -16.46% | -22.21% | -27.93% | -33.49% |
EBITDA | 13.76 | -14.11 | 61.29 | 125.74 | 6.08 |
EBITDA Margin | 2.47% | -2.41% | 9.62% | 17.22% | 1.11% |
D&A For EBITDA | 51.2 | 42.56 | 39.68 | 29.39 | 26.88 |
EBIT | -37.44 | -56.68 | 21.61 | 96.35 | -20.8 |
EBIT Margin | -6.72% | -9.69% | 3.39% | 13.20% | -3.80% |
Effective Tax Rate | - | - | - | 7.17% | 31.04% |